お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
363397

心臓ペースメーカーの世界市場:医療機器のパイプライン評価

Pacemakers - Medical Devices Pipeline Assessment, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 117 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.06円
心臓ペースメーカーの世界市場:医療機器のパイプライン評価
出版日: 2019年12月18日
発行: GlobalData
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の心臓ペースメーカーの市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 心臓ペースメーカーの概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 心臓ペースメーカーの企業:治験段階別のパイプライン製品
  • 心臓ペースメーカー:治験段階別のパイプライン製品

第5章 心臓ペースメーカー市場:企業・製品の概要

  • Boston Scientific Corporation
    • パイプライン製品および進行中の治験の概要
  • Boston TransTec, LLC
  • Duke University
  • EBR Systems, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LivaNova PLC
  • Mathematical Bio-Solutions Inc.
  • Mayo Clinic US
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NDSU Research Foundation
  • NuVascular Technologies Inc
  • Perpetuum Ltd.
  • St. Jude Medical, Inc.
  • University of Bern
  • University of California, Los Angeles
  • University of Michigan

第6章 心臓ペースメーカー市場:昨今の動向 (全63件)

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Pacemakers - Pipeline Products by Stage of Development
  • Table 2: Pacemakers - Pipeline Products by Segment
  • Table 3: Pacemakers - Pipeline Products by Territory
  • Table 4: Pacemakers - Pipeline Products by Regulatory Path
  • Table 5: Pacemakers - Pipeline Products by Estimated Approval Date
  • Table 6: Pacemakers - Ongoing Clinical Trials
  • Table 7: Pacemakers Companies - Pipeline Products by Stage of Development
  • Table 8: Pacemakers - Pipeline Products by Stage of Development
  • Table 9: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Wireless Pacemaker System - Product Status
  • Table 11: Wireless Pacemaker System - Product Description
  • Table 12: AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: AtaCor Pacing System - Product Status
  • Table 14: AtaCor Pacing System - Product Description
  • Table 15: AtaCor Medical Inc - Ongoing Clinical Trials Overview
  • Table 16: AtaCor Pacing System - Subcostal Temporary Extracardiac Pacing Study: Clinical Study of the AtaCor Extracardiac Pacing System
  • Table 17: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: EMPOWER Leadless Pacer - Product Status
  • Table 19: EMPOWER Leadless Pacer - Product Description
  • Table 20: INGENIO 2 PG - MICS - Product Status
  • Table 21: INGENIO 2 PG - MICS - Product Description
  • Table 22: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Raul Pacemaker - Product Status
  • Table 24: Raul Pacemaker - Product Description
  • Table 25: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Biological Pacemaker - Product Status
  • Table 27: Biological Pacemaker - Product Description
  • Table 28: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Tissue-Engineered Autonomous Pacemaker - Product Status
  • Table 30: Tissue-Engineered Autonomous Pacemaker - Product Description
  • Table 31: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Aortic Pacemaker - Product Status
  • Table 33: Aortic Pacemaker - Product Description
  • Table 34: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: InnerPulse Pacemaker - Product Status
  • Table 36: InnerPulse Pacemaker - Product Description
  • Table 37: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Unconditional MRI Compatible Implantable Pacemaker - Product Status
  • Table 39: Unconditional MRI Compatible Implantable Pacemaker - Product Description
  • Table 40: Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Wireless Pacemaker - Product Status
  • Table 42: Wireless Pacemaker - Product Description
  • Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Brady Wireless - Product Status
  • Table 45: Brady Wireless - Product Description
  • Table 46: Heart Pacemaker - Product Status
  • Table 47: Heart Pacemaker - Product Description
  • Table 48: Micra AR - Product Status
  • Table 49: Micra AR - Product Description
  • Table 50: Micra AV - Product Status
  • Table 51: Micra AV - Product Description
  • Table 52: Micra DDD Pacemaker - Product Status
  • Table 53: Micra DDD Pacemaker - Product Description
  • Table 54: Percepta Quad CRT-P MRI SureScan - Product Status
  • Table 55: Percepta Quad CRT-P MRI SureScan - Product Description
  • Table 56: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 57: Percepta Quad CRT-P MRI SureScan - BlueSync Field Evaluation
  • Table 58: Percepta Quad CRT-P MRI SureScan - Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study
  • Table 59: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Reply MRI Pacemaker - Product Status
  • Table 61: Reply MRI Pacemaker - Product Description

List of Figures

  • Figure 1: Pacemakers - Pipeline Products by Stage of Development
  • Figure 2: Pacemakers - Pipeline Products by Segment
  • Figure 3: Pacemakers - Pipeline Products by Territory
  • Figure 4: Pacemakers - Pipeline Products by Regulatory Path
  • Figure 5: Pacemakers - Pipeline Products by Estimated Approval Date
  • Figure 6: Pacemakers - Ongoing Clinical Trials
目次
Product Code: GDME0874EPD

GlobalData's Medical Devices sector report, "Pacemakers - Medical Devices Pipeline Assessment, 2019" provides an overview of Pacemakers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pacemakers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Pacemakers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Pacemakers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Pacemakers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 8

  • 2.1 Pacemakers Overview 8

3 Products under Development 9

  • 3.1 Pacemakers - Pipeline Products by Stage of Development 9
  • 3.2 Pacemakers - Pipeline Products by Segment 10
  • 3.3 Pacemakers - Pipeline Products by Territory 11
  • 3.4 Pacemakers - Pipeline Products by Regulatory Path 12
  • 3.5 Pacemakers - Pipeline Products by Estimated Approval Date 13
  • 3.6 Pacemakers - Ongoing Clinical Trials 14

4 Pacemakers - Pipeline Products under Development by Companies 15

  • 4.1 Pacemakers Companies - Pipeline Products by Stage of Development 15
  • 4.2 Pacemakers - Pipeline Products by Stage of Development 16

5 Pacemakers Companies and Product Overview 17

  • 5.1 Arizona State University Company Overview 17
    • 5.1.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.2 AtaCor Medical Inc Company Overview 18
    • 5.2.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.3 Boston Scientific Corp Company Overview 21
    • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Boston TransTec LLC Company Overview 23
    • 5.4.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Columbia University Company Overview 24
    • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 Duke University Company Overview 25
    • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 Hadassah Medical Center Company Overview 26
    • 5.7.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 InnerPulse Inc (Inactive) Company Overview 27
    • 5.8.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.9 Kenergy Inc. Company Overview 28
    • 5.9.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.10 Krisara Engineering, LLC Company Overview 29
    • 5.10.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.11 Medtronic plc Company Overview 30
    • 5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 MicroPort CRM Company Overview 37
    • 5.12.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.13 MicroPort Scientific Corp Company Overview 38
    • 5.13.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.14 NuVascular Technologies Inc Company Overview 39
    • 5.14.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.15 Osypka Medical GmbH Company Overview 40
    • 5.15.1 Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.16 Perpetuum Ltd Company Overview 42
    • 5.16.1 Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.17 Rice University Company Overview 43
    • 5.17.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.18 St. Jude Medical LLC Company Overview 44
    • 5.18.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.19 Thayer School of Engineering at Dartmouth Company Overview 47
    • 5.19.1 Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.20 U.S. Stem Cell Inc Company Overview 48
    • 5.20.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.21 University of Bern Company Overview 49
    • 5.21.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.22 University of Michigan Company Overview 50
    • 5.22.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.23 University of Southern California Company Overview 51
    • 5.23.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 51

6 Pacemakers- Recent Developments 53

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 53
  • 6.2 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 55
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 56
  • 6.4 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 57
  • 6.5 Nov 11, 2019: New study shows promise in treating more patients with world's smallest pacemaker 57

7 Appendix 114

  • 7.1 Methodology 114
  • 7.2 About GlobalData 117
  • 7.3 Contact Us 117
  • 7.4 Disclaimer 117
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.